Q3 Earnings Season Winners: 3 Companies Raising Guidance
BWX Technologies (BWXT), Johnson & Johnson (JNJ), and UnitedHealth Group (UNH) raised FY26 guidance after strong Q3 earnings. BWXT reported 18% revenue growth and raised EPS guidance to $4.70–$4.80. JNJ saw 5.9% sales growth and increased EPS outlook to $11.10. UNH improved medical cost trends and raised EPS guidance to at least $20.50. All three companies cited improving business trends.
How this was made

The 30-second read
Why it matters
While the guidance updates are positive, they repeat information already public, limiting new trading opportunities.
Market read
Guidance lifts may provide modest upside for each stock but are largely already priced in.
What to watch
Potential regulatory or supply‑chain risks in nuclear and healthcare segments could temper upside.
Background
The article recaps recent FY26 guidance raises for three large U.S. companies after their quarterly results, which were released weeks earlier.
Ticker impact
BWX Technologies raised FY26 adjusted EPS guidance to $4.70‑$4.80 after reporting 18% revenue growth and a 72% jump in commercial sales.
likely upward pressure as investors price in higher EPS expectations
Management's guidance lift follows solid quarterly results, indicating continued momentum in the nuclear segment.
Johnson & Johnson increased FY26 adjusted EPS midpoint to $11.10 after a 5.9% revenue rise to $25.4 bn, driven by Innovative Medicine growth.
moderate upside as the market absorbs the higher EPS target
The EPS lift, though small, reflects steady sales growth and may lift sentiment toward the stock.
UnitedHealth Group raised FY26 adjusted EPS outlook to at least $20.50 after medical care ratio improved to 88.4% and operating earnings rose to $6.6 bn.
potential upward pressure as investors value improved cost ratio and earnings expansion
Improved medical care ratio and higher operating earnings underpin the EPS upgrade, supporting a bullish view.
Market effects
Highlights strength in healthcare and nuclear components sectors, possibly boosting related peers.
U.S. large‑cap health and industrial stocks may see modest gains.
Limited; primarily U.S. equity impact.
Counterpoint
Guidance lifts are modest relative to company size; price may already reflect expectations.
Key entities
- CompanyBWX Technologies
Nuclear components and services provider.
- CompanyJohnson & Johnson
Diversified health and consumer products firm.
- CompanyUnitedHealth Group
Health insurance and services conglomerate.

